Platform

What you get with Vima Access.

Two layers. Six panels of data, four workflows on top. Worked together so your team can ask any question about any drug and act on the answer.

The data layer

Six panels per drug. Every panel sourced, dated, verified.

01

Product information

dm+d-linked names (brand and generic), VMP/AMP classification, identifiers, strengths, pack sizes, list prices, BNF chapter, controlled-drug status.

Source
TRUD dm+d
Cadence
Refreshed weekly from TRUD.
Why it matters
The regulatory baseline every other panel hangs off. BNF code joins to NHSBSA EPD; VMP joins to Drug Tariff.
02

Prescribing trends

National and ICB-level monthly items and cost, 12 months by default. Brand-aware aggregation across strengths. PCN drilldown. Year-on-year benchmarking.

Source
NHSBSA EPD
Cadence
Monthly. Inherent ~2-month publication lag from the source.
Why it matters
Where is the drug actually being used? Which ICBs are over- or under-indexed? Quantified, not anecdotal.
03
Most asked

ICB formulary status

All 42 current ICBs. Listed / Restricted / Not Listed / Under Review status per ICB. Restriction notes. Prescriber-level. Source URL on every record.

Source
Curated by Vima Clinical
Cadence
Reviewed quarterly. Updated as changes occur.
Why it matters
The single most-asked question by brand managers, instantly answered, with the formulary PDF one click away.
04

Clinical system listings

EMIS Web, SystmOne, Vision, ProScript Connect. Per-drug, per-system listing status, listing date, screenshot evidence, notes.

Source
Curated by Vima Clinical
Cadence
Continuous. Updated as listings change.
Why it matters
Every analyst's most painful manual research task. Pre-curated, evidence-attached, ready to read.
05

Wholesaler listing audit

AAH, Alliance Healthcare, Phoenix. Listing status, catalogue name, PIP code, listed price. Per-wholesaler margin against Drug Tariff or active concession. Screenshot evidence per record.

Source
Curated by Vima Clinical
Cadence
Quarterly catalogue audit.
Why it matters
Catalogue accuracy is the single biggest preventable cause of prescribing friction. Margin calculation surfaces where the dispensing pharmacy makes or loses money.
06

Reimbursement

Drug Tariff category (Cat A / Cat C / Cat M / Not listed), list price, ACBS approval, current concession price, concession period.

Source
NHSBSA Drug Tariff
Cadence
Monthly, aligned to NHSBSA Drug Tariff updates.
Why it matters
Reimbursement intelligence without scrolling NHSBSA tables. Concession alerts surface in your watchlist automatically.
The workflow layer

Four workflows that turn data into decisions.

Built on top of the panels. Watched, Proposals, and Support are included with every subscription. Launch Tracker is available as an optional per-launch add-on.

01

Watched drugs and alerts

Watch any drug in your portfolio with one click. Get email when something changes: formulary status moves, listing appears, wholesaler stops stocking, dm+d entry amended.

How it works
  1. 01Click 'Watch' on any drug page or set defaults by therapy area.
  2. 02Choose immediate, 08:00 UK daily digest, weekly Monday digest, or in-platform only.
  3. 03Email contains the change, the source link, and a deep link back to the platform.
Who uses it
Brand manager, market access lead, commercial analyst, regulatory affairs.
Included
Included with every subscription.
02

Formulary proposals

When a Panel 3 row is out of date, your team proposes the edit with a citable source. Vima reviews. Approved proposals write to the live formulary entry in a single atomic transaction.

How it works
  1. 01Spot an out-of-date row, hit 'Suggest a change', describe the edit, attach a source (APC minutes, NICE TA, NHS comms).
  2. 02Vima Clinical reviews, with a one-active-proposal-per-drug-ICB rule so suggestions never conflict.
  3. 03On approval the change goes live and your team gets an email confirming it. The audit log records actor and time.
Who uses it
Market access lead, field team, regulatory affairs.
Included
Included with every subscription.
03
Add-on

Launch Tracker

End-to-end view of a launch, anchored on the dm+d effective date. Six milestone categories, auto-detection from panel data, slip-risk warnings, daily email digest.

How it works
  1. 01Add a launch to the tracker with the dm+d effective date and the launch type (new product, pack change, ACBS).
  2. 02Vima auto-detects milestones from the panels (wholesaler appearance, EMIS listing, first prescription).
  3. 03Slip-risk warnings fire when the cadence drifts. Daily 08:00 UK digest covers every watched launch.
Who uses it
Brand manager owning a specific launch, plus commercial and market access stakeholders watching from the side.
Included
Available as an optional per-launch add-on, priced per launch event.
04

Support tickets

Threaded conversation with Vima Clinical for everything not covered by a structured workflow: data corrections, onboarding, configuration asks, general queries.

How it works
  1. 01Categorise by topic (dm+d, formulary, listings, wholesaler, reimbursement, onboarding, general). Optionally attach a drug.
  2. 02Attach files up to 5 MB (PDF, JPG, PNG, WebP) for APC minutes, supplier emails, screenshots.
  3. 03Four-state flow (Open, In progress, Awaiting client, Resolved) with email at every transition.
Who uses it
Anyone in the client org with portal access.
Included
Included with every subscription.
ICB coverage

All 42 ICBs. Ready for the post-April-2026 mergers as they land.

England has 42 Integrated Care Boards today. Vima Access populates formulary status and central clinical system deployments for every one of them.

Further mergers are planned from April 2026 onward. The platform has built-in admin merge tooling that reassigns formulary records, infrastructure records, and historical data to merged ICBs, so you do not lose continuity of intelligence when the geography shifts.

For mapping, we use a hex tile grid rather than a real geographic map. Every ICB gets equal visual weight: the small London ICBs are visible and clickable, not crammed into a smudge. It is the format the FT and Bloomberg use for political and healthcare data, for the same reason.

Every formulary record links back to the source PDF on the ICB’s website. Every record carries a last-verified date and a named verifier.

Operational trust

What you would expect from a system of record.

Approved formulary changes are atomic. Every record change has an author, a timestamp, and a before-and-after. Every upstream ingest has a traffic-light health view inside the admin home.

Audit log
Every record change is captured with actor, before, after, and timestamp. Append-only.
Ingest health
TRUD dm+d and NHSBSA EPD pipelines surface a green/amber/red status on the admin home.
Atomic approvals
When Vima approves a formulary proposal, the write to the live entry and the proposal status update happen in a single Postgres transaction. No half-applied state.

See it with your products.

We’ll seed the platform with the drugs you tell us about and walk you through a real, live record. Not a generic example.

Request a demo →